High Purity Peptides | Fast Worldwide Shipping

IGF1-LR3 1mg

IGF1-LR3 1mg

IGF-1 LR3 is a 83-residue analog of insulin-like growth factor 1, modified with an Arg³ substitution and a 13-residue N-terminal extension that sharply reduce IGFBP binding. Supplied as a ≥95% HPLC-verified lyophilized powder for laboratory research use only.

+99% Purity Third-Party Tested COA Available

 64.99

Out of stock

In stock – Ships same day
SSL Secured
Secure Checkout
Guaranteed Delivery
Third-Party Tested

Certificate of Analysis

Third-Party Tested by Janoshik Analytical

Latest
92.577%
Purity
Variant
IGF1-LR3 1mg
Lot #
igf1-2605
Labeled
IGF-1 LR3 1 mg
Actual
N/A
Tested
Apr 29, 2026
View Certificate

Compound Information

Technical specifications


Molecular Profile

What Is IGF-1 LR3?

TypeRecombinant IGF-1 Analog (Growth Factor)
CAS Number946870-92-4
Molecular Weight9111.00 g/mol (approx.)
SynonymsLong R3 IGF-1 / LR3 IGF-1
Amino Acids83 AA (70 AA IGF-1 core + 13 AA N-terminal extension)
ModificationsArg³ substitution (Glu→Arg) + 13 AA N-terminal peptide
FormulaC400H625N111O115S9

Storage Requirements

Stability Information

Lyophilized powder; keep sealed, dry, and protected from light
A folded protein — more sensitive to heat and agitation than short peptides
Three disulfide bridges — avoid reducing agents in the working buffer

Lyophilized Powder

-20°C preferred; 2–8°C for short-term handling

Reconstituted

2–8°C; aliquot and avoid freeze–thaw


About IGF-1 LR3

IGF-1 LR3 (Long R3 IGF-1) is a recombinant analog of insulin-like growth factor 1, carrying two engineered changes: an arginine substitution at position 3, and a 13-residue extension on the N-terminus. Both modifications serve the same purpose — sharply reducing the protein’s affinity for IGF-binding proteins (IGFBPs), which in native IGF-1 sequester the vast majority of circulating hormone. The result is an analog that remains available to engage the IGF-1 receptor rather than being bound up in complex. This makes LR3 a widely used tool in cell culture, where it is a standard supplement in serum-free media, and in studies of IGF-1R signaling, PI3K/Akt pathway activation, and cellular proliferation. Supplied as a high-purity lyophilized powder. This product is for laboratory research and development purposes only and must be handled by qualified professionals. Not for human, therapeutic, or diagnostic use.


Research Highlights

Reduced IGFBP Binding

Both the Arg³ substitution and the N-terminal extension sharply lower affinity for binding proteins that sequester native IGF-1.

Cell Culture Standard

A common supplement in serum-free and reduced-serum media, where its BP-resistance makes it more reliably active than native IGF-1.

PI3K/Akt Pathway Studies

Engages IGF-1R to activate the PI3K/Akt cascade — a central axis in proliferation, survival, and protein synthesis research.

Cellular Proliferation

Widely used to drive growth and division in cultured cell lines, including myoblast and fibroblast models.

Recombinant Protein

Unlike the short peptides in this catalog, LR3 is a folded 83-residue protein with three disulfide bridges — handle accordingly.

≥95% HPLC Purity

Every batch is HPLC-verified and supplied lyophilized, ensuring reproducible activity across long study timelines.

Product Specifications

Molecular Formula
C400H625N111O115S9
Molecular Weight
9111.00 g/mol (approx.)
CAS Number
946870-92-4
Length
83 amino acids (70 AA IGF-1 core + 13 AA N-terminal extension)
Purity
≥95% (HPLC verified)
Form
Lyophilized powder
Appearance
White to off-white powder
Solubility
Soluble in dilute acetic acid; also bacteriostatic water
Storage
-20°C (lyophilized), 2–8°C (reconstituted)

Research Studies

Frequently Asked Questions

What is IGF-1 LR3?

IGF-1 LR3 is a recombinant analog of insulin-like growth factor 1, carrying an arginine substitution at position 3 and a 13-residue N-terminal extension.

What do the LR3 modifications actually do?

Both changes sharply reduce affinity for IGF-binding proteins, which normally sequester most native IGF-1. The analog therefore remains available to engage the IGF-1 receptor rather than being bound up in complex.

How does handling differ from short peptides?

LR3 is a folded 83-residue protein with three disulfide bridges, not a short linear peptide. It is more sensitive to heat, agitation, and reducing agents, and should be aliquoted rather than repeatedly freeze-thawed.

Is this product approved for human use?

No. This product has not been evaluated by the FDA and is strictly intended for research and development purposes by qualified professionals only.

IGF-1 LR3 molecular structure

Summer Sale • 10% OFF Use Coupon SUMMER10

X